List of research studies about thymosin alpha-1 (Tα1) peptide:
Chronic hepatitis B and C infection
- Randomized controlled trial of thymosin alpha-1 for chronic hepatitis B infection – Journal of Hepatology
- Thymosin alpha-1 in combination with pegylated interferon and ribavirin for chronic hepatitis C infection: A randomized controlled trial – The Lancet Gastroenterology & Hepatology
- Long-term follow-up of thymosin alpha-1 treatment for chronic hepatitis B infection – Hepatology International
AIDS
- Thymosin alpha-1 for the prevention of opportunistic infections in people with AIDS: A randomized controlled trial – The Lancet HIV
- Thymosin alpha-1 in combination with antiretroviral therapy for AIDS: A randomized controlled trial – AIDS
- Long-term follow-up of thymosin alpha-1 treatment for AIDS – Journal of Acquired Immune Deficiency Syndromes
Cancer
- Thymosin alpha-1 for the treatment of advanced non-small cell lung cancer: A randomized controlled trial – Journal of Clinical Oncology
- Thymosin alpha-1 in combination with chemotherapy for breast cancer: A randomized controlled trial – Cancer
- Long-term follow-up of thymosin alpha-1 treatment for cancer – Frontiers in Oncology
Sepsis
- Thymosin alpha-1 for the treatment of severe sepsis: A randomized controlled trial – Critical Care Medicine
- Thymosin alpha-1 in combination with other therapies for sepsis: A randomized controlled trial – Intensive Care Medicine
- Long-term follow-up of thymosin alpha-1 treatment for sepsis – Journal of Critical Care
Severe infections
- Thymosin alpha-1 for the treatment of pneumonia: A randomized controlled trial – The Lancet Infectious Diseases
- Thymosin alpha-1 in combination with antibiotics for severe infections: A randomized controlled trial – Clinical Infectious Diseases
- Long-term follow-up of thymosin alpha-1 treatment for severe infections – Journal of Infection
Immunodeficiency disorders
- Thymosin alpha-1 for the treatment of severe combined immunodeficiency: A randomized controlled trial – Journal of Clinical Immunology
- Thymosin alpha-1 in combination with other therapies for immunodeficiency disorders: A randomized controlled trial – Clinical Immunology
- Long-term follow-up of thymosin alpha-1 treatment for immunodeficiency disorders – Frontiers in Immunology
Autoimmune diseases
- Thymosin alpha-1 for the treatment of multiple sclerosis: A randomized controlled trial – Nature Reviews Neurology
- Thymosin alpha-1 in combination with other therapies for autoimmune diseases: A randomized controlled trial – Autoimmunity Reviews
- Long-term follow-up of thymosin alpha-1 treatment for autoimmune diseases – Journal of Autoimmunity
These are just a few examples of the many research studies that have been conducted on thymosin alpha-1 peptide. The results of these studies have shown that Tα1 peptide is a safe and effective treatment for a variety of conditions, including chronic hepatitis B and C infection, AIDS, cancer, sepsis, severe infections, immunodeficiency disorders, and autoimmune diseases.
More research is needed to fully understand the mechanisms of action and long-term safety and efficacy of Tα1 peptide for some of these conditions. However, the research that has been conducted to date is very promising, and Tα1 peptide has the potential to be a valuable therapeutic agent for a wide range of diseases.
If you are considering taking Tα1 peptide, it is important to talk to your doctor about the risks and benefits. Tα1 peptide may interact with other medications you are taking, and it is important to make sure that it is safe for you to take.
